- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Crystal Lake Today
By the People, for the People
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
The collaboration aims to accelerate the development of a product with the potential to help patients globally.
Mar. 13, 2026 at 2:18am
Got story updates? Submit your updates here. ›
Aptar Pharma, a global leader in drug delivery and dosing technologies, has announced a technical collaboration with COVIRIX Medical, an Australian company developing a portfolio of antiviral treatments. The partnership will focus on accelerating the development of inhalable antiviral treatments that can address several global health challenges.
Why it matters
The collaboration between Aptar Pharma and COVIRIX Medical brings together expertise in drug delivery and antiviral development, which could lead to innovative treatments that improve patient access and outcomes for various viral infections worldwide.
The details
Through the collaboration, Aptar Pharma will leverage its drug delivery and dosing technologies to support the development of COVIRIX Medical's antiviral treatments, which are designed to be administered through inhalation. This approach aims to improve the effectiveness and accessibility of antiviral therapies for patients globally.
- The partnership was announced on March 13, 2026.
The players
Aptar Pharma
A global leader in drug delivery, dosing, protection technologies and services.
COVIRIX Medical Pty Ltd
An Australian company developing a portfolio of antiviral treatments.
The takeaway
This partnership between a leading drug delivery company and an innovative antiviral developer highlights the potential for collaborative efforts to address global health challenges through the development of accessible and effective treatments.
